SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-308400
Filing Date
2014-08-13
Accepted
2014-08-13 16:10:45
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d745367d10q.htm 10-Q 234292
2 EX-31.1 d745367dex311.htm EX-31.1 6886
3 EX-31.2 d745367dex312.htm EX-31.2 7141
4 EX-32.1 d745367dex321.htm EX-32.1 3022
5 EX-32.2 d745367dex322.htm EX-32.2 3125
  Complete submission text file 0001193125-14-308400.txt   1786608

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT evok-20140630.xml EX-101.INS 206135
7 XBRL TAXONOMY EXTENSION SCHEMA evok-20140630.xsd EX-101.SCH 19760
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evok-20140630_cal.xml EX-101.CAL 27200
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evok-20140630_def.xml EX-101.DEF 58014
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE evok-20140630_lab.xml EX-101.LAB 166697
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evok-20140630_pre.xml EX-101.PRE 113285
Mailing Address 505 LOMAS SANTA FE DRIVE SUITE 270 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE DRIVE SUITE 270 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36075 | Film No.: 141037608
SIC: 2834 Pharmaceutical Preparations